Semantic Coherence: Medidata (Dassault Systèmes) – Signal Evidence & AI Readability

[H1]
Powering Smarter Treatments and Healthier People
Managing clinical research demands more than disconnected systems; it requires an intelligent platform that links Patient, Data, and Study Experiences.

Why Experiences

[H3]
Get the Report

Discover how early AI adoption is transforming every stage of the trial lifecycle in our 2nd annual State of AI in Clinical Trials report.

[H2]
Why Medidata

[H3]
Chosen Technology

0
%

of FDA novel drug approvals used Medidata

in 2025

[H3]
TRUSTED IN

0
K+

clinical trials

[H3]
AI FOR IMPACT BUILT ON

0
B

data points annually

[H3]
USED BY

0
M+

patients

[H2]
Experiences

Discover the Medidata Platform

[H3]
Patient Experience

How do you reduce patient burden across every trial stage?

Explore Experience

[H3]
Data Experience

How do AI and automation make your data workflows run themselves?

Explore Experience

[H3]
StudyExperience

How do you accelerate study delivery with AI-driven insights?

Explore Experience

[H2]
Who We Work With

See Their Success Stories

[IMG: 0005_everest]
[IMG: MDS_Homepage_CompanyLogo_V2_onconova 2]
[IMG: MDS_Homepage_CompanyLogo_V2_medicenna 2]
[IMG: MDS_Homepage_CompanyLogo_V2_rezolute 2]
[IMG: 0011_eClinical]
[IMG: MDS_Homepage_CompanyLogo_V2_conformal 2]

[IMG: MDS_Homepage_CompanyLogo_V2_ptc 2]
[IMG: MDS_Homepage_CompanyLogo_V2_stryker 2]
[IMG: MDS_Homepage_CompanyLogo_V2_aperio 2]
[IMG: MDS_Homepage_CompanyLogo_V2_richmond 2]
[IMG: MDS_Homepage_CompanyLogo_V2_icon 2]

[H2]
Results Proven at Scale
across Therapeutic Areas, Sponsors, and CROs.

See Case Studies

[H3]
Quanticate Accelerates Go-live and Expands Trial Pipelines

0
%

reduction in study build times

[H3]
Global CRO Achieves Study Setup in Just Four to Six Weeks

0
%

slashed from “go-live” times

[H3]
Mid-sized Sponsor Increased Site Count by 50% in a Rare Disease Clinical Trial

0
%

increase in site count in a rare disease trial

[H2]
Real Impact across Every Role

Data

Operations

IT

Regulatory

[H3]
Data

[IMG: Video thumbnail]

[H3]
ICON Harmonizes Clinical Risk Management, Data Management, and Medical Review teams through Clinical Data Studio
There are cost reductions, and we’re able to expedite timelines. We’re getting listings live at first-patient-in. We’re getting triangular review done—we’re getting manual review done faster.

Luke Gregory

Senior Director, Clinical Systems

[H3]
Operations

[IMG: Video thumbnail]

[H3]
PROMETRIKA Discovers the Power of a Unified Platform
Medidata’s RTSM solution gives PROMETRIKA a competitive advantage... There is great benefit in having everything sit on the same platform.

Miganush Stepanians

President and CEO

[H3]
IT

[IMG: Video thumbnail]

[H3]
Everest Clinical Research Scales with Medidata to Better Support Customers
We just find that the quality of the solution, the level of support that we get, and the scalability really helps us support our customers

Jin Dai

Chief Operating Officer

[H3]
Regulatory

[IMG: Video thumbnail]

[H3]
Phase III Glioblastoma Trial Experiences Breakthrough with Synthetic Control Arm®
What we were able to get from the FDA was, in fact, the very first design of a Phase III registration trial, where the majority of patients would come from an external control arm... that was a big accomplishment for us.

Fahar Merchant

President and CEO

[H3]
Awards and Recognition

2024

20242025

2025

2025

20242025

20242025

2025

[H3]
The Latest
New. Now. Noteworthy.
Discover the breakthroughs shaping what's next.

Go to Newsroom

[H4] Medidata Champions Collaborative Scientific Advancement at ASCO with New Research on Oncology Protocol Optimization and CAR T Efficacy

[H4] Medidata’s Next-Gen AI Imaging Solution Delivers Unprecedented Speed and Precision for Clinical Trials

[H4] Medidata’s Second Annual AI Report Shows a Shift from Pilots to Enterprise Adoption with 72.9% of Early Adopters Seeing a Reduction in Study Timelines

[H4] Worldwide Clinical Trials and Medidata Announce Strategic Partnership to Embed Medidata AI Across the Full Trial Lifecycle, Bolstering Study Execution and Delivery Excellence

[H1]
Built on Experience
For 25+ years, Medidata has redefined clinical development to accelerate smarter treatments and healthier lives—and continues to shape what comes next.

[H2]
Powering Smarter Treatments and Healthier People

Medidata, a Dassault Systèmes’ brand and global leader in clinical trial solutions, has driven ground-breaking technological innovation across 38,000+ trials and 12 million patients, delivering industry-leading expertise, analytics-powered insights, and one of the largest clinical trial data sets in the industry.Today, one million users across 2,300 organizations trust our seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster.


[H2]
Leadership

[H3] Tarek Sherif

Life Sciences & Healthcare Sector Board Chairman for Dassault Systèmes

[H3] Anthony Costello

Chief Executive Officer

[H3] Janet Butler

EVP, Head of Global Sales

[H3] Tom Doyle

SVP, Chief Technology Officer

[H3] Rick Goldstein

EVP, Chief Legal Officer

[H3] Linda Magrath

SVP, Head of Customer Success, Services & Support

[H3] Lisa Moneymaker

SVP, Chief Strategy Officer

[H3] Edwin Ng

SVP, General Manager, Asia Pacific

[H3] Matt Noble

SVP, Head of Patient Experience

[H3] Joe Schmidt

Chief Operating Officer

[H3] Josh Schwartz

SVP, Chief Financial Officer

[H3] Esmerita Sepulveda-Lusky

SVP, Head of People

[H3] Alicia Staley

SVP, Chief Patient Officer

[H2]
Our Story
Medidata was founded to drive smarter treatments and healthier lives. 

What followed is a 25+ year journey of milestones that reshaped clinical development—and continue to define what’s next.

[H3]
Medidata Is Founded
Fund manager Tarek Sherif moves into a small office with tech entrepreneur and researcher Glen de Vries, who hand-codes Medidata’s original software. Together with Ed Ikeguchi, they found Medidata.

[H4]
June 1999

[H3]
EDC Launches
The first software to digitally collect clinical trial data. Later named Rave EDC (Electronic Data Capture), it transforms 
data capture to become the world’s most advanced, robust, and secure system for managing clinical trial site, patient, and lab data.

[H4]
June 1999

[H3]
Medidata Opens London Office

[H4]
June 2004

[H3]
Medidata Opens Tokyo Office

[H4]
June 2005

[H3]
Medidata NEXT Launches
A Rave best-practices forum, the Medidata User Group (MUG), becomes Medidata Symposium in 2015 and Medidata NEXT in 2017. Today, it convenes industry leaders and patient advocates 
to shape the future of life sciences.

[H4]
2006

[H3]
Initial Public Offering on NASDAQ

[H4]
June 2009

[H3]
Acquisition of Clinical Force
Adds Medidata CTMS® (Clinical Trial Management System) to solutions.

[H4]
June 2011

[H3]
Acquisition of Mytrus
Adds eConsent to the Medidata Platform.

[H4]
April 2017

[H3]
Acquisition of CHITA
Adds regulated content management and eTMF capabilities to the Medidata Platform.

[H4]
June 2017

[H3]
Acquisition of SHYFT Analytics
Powers customers’ digital transformation 
with AI and real-world analytics.

[H4]
June 2018

[H3]
Launches Medidata AI
Combines data, technology, and deep expertise to deliver actionable insights across the clinical development continuum—optimizing study execution and commercial success, and proving therapy value.

[H4]
June 2019

[H3]
Dassault Systèmes Acquires Medidata
Dassault Systèmes, the 3DEXPERIENCE company, acquires Medidata to accelerate the digital transformation of life sciences —pushing the boundaries of innovation and learning to build 
a more sustainable future for patients and society.

Read More

[H4]
October 2019

[H3]
Responding to COVID-19 with Data and Direction
Throughout 2020, Medidata publishes nine white papers analyzing COVID-19’s impact on drug and vaccine trials—assessing patient disruption and delivering data-driven guidance to help sponsors and CROs sustain and adapt studies worldwide.

[H4]
March 2020

[H3]
Launches myMedidata
Built for and with patients, myMedidata is an award-winning portal enabling participants to learn, enroll, and engage in trials from any device—powering scalable, flexible, decentralized, and hybrid study models.

[H4]
April 2020

[H3]
Powers Moderna’s COVID-19 Vaccine Trials
Medidata’s cloud platform enables the rapid advancement of Moderna’s mRNA-1273 program, supporting its 30,000-participant Phase 3 study with the scale, speed, and resilience required during the global pandemic.

Press Release

[H4]
July 2020

[H3]
Medidata Synthetic Control Arm® Supported by the FDA
In a regulatory first, the FDA permits Medicenna to use 
a hybrid external control arm in a Phase 3 registrational trial—building on a Phase 2 study in recurrent glioblastoma strengthened by Medidata’s Synthetic Control Arm®.

Press Release

[H4]
October 2020

[H3]
Launches 
myMedidata Registries
Expanding our patient portal to engage participants before enrollment and long after trial completion supports long-term follow-up and safety surveillance.

Press Release

[H4]
June 2021

[H3]
Introduces the First Unified Platform for DCTs
The industry’s first end-to-end, secure platform for decentralized clinical trials enables sponsors and CROs to manage drug, vaccine, and device studies seamlessly across the development continuum.

Press Release

[H4]
June 2021

[H3]
Launches Sensor Cloud and the Sensor Cloud Network
Delivering advanced data models and proprietary algorithms that rapidly ingest, normalize, and analyze patient-generated data accelerates decisions and timelines. The Sensor Cloud Network unites CROs, device makers, sponsors, analytics firms, and academia in the industry’s first cross-sector collaboration.

Read More

[H4]
October 2021

[H3]
Rave Imaging Surpasses 1,000 Studies
Exceeding 1,000 supported trials, Rave Imaging processes more than 100 million images annually—scaling secure, cloud-based imaging management 
for global clinical research.

[H4]
October 2021

[H3]
Remembering Glen de Vries
Glen set the highest standard for Medidata and championed our commitment to always innovate to solve our industry’s most complex problems. 
We will further Glen’s mission by continuing to push the boundaries of what’s possible.

Read More

[H4]
November 2021

[H3]
Opens up Patient Insights Program
Enabling sponsors, CROs, and sites to embed patient perspectives directly into software design and improve the clinical research experience.

Read More

[H4]
February 2022

[H3]
30,000 Trials, 9 Million Participants
The first life sciences technology company to surpass 30,000 trials and 9 million study volunteers.

Press Release

[H4]
March 2023

[H3]
Showcases Clinical Data Studio and Health Record Connect
New experiences for enhancing and streamlining clinical data workflows.

[H4]
November 2023

[H3]
Anthony Costello Named CEO
Anthony Costello has advanced the use of technology in clinical trials for nearly 30 years. Across numerous leadership roles from entrepreneur to corporate c-suite, Anthony has transformed the patient, site, and sponsor experience, while accelerating the delivery of life-changing treatments.

[H4]
March 2024

[H3]
Recognized for Site Innovation
Medidata was presented with the inaugural Site Innovation Award for its groundbreaking work in improving efficiency in clinical trials by the Summit for Clinical Ops Executives (SCOPE).

Press Release

[H4]
March 2024

[H3]
Global Rollout of Clinical Data Studio
Delivers a unified research experience with greater data quality control.

Clinical Data Studio

[H4]
March 2024

[H3]
Launches
Patient Payments
A new solution for streamlining trial-related stipends and reimbursements for patients participating in clinical research.

Patient Payments

[H4]
September 2024

[H3]
Introduces Rave Lite
An extension of its gold-standard clinical research software, Rave EDC, and designed explicitly for Phase I and IV studies.

Rave Lite

[H4]
October 2024

[H3]
Enters CNS Space with Cogstate Partnership
A partnership with neuroscience solutions leader Cogstate reshapes clinical trials and outcomes measurement for central nervous system (CNS) diseases across neurodegenerative, psychiatric, motor, and rare neurodevelopmental disorders.

Press Release

[H4]
October 2024

[H3]
35,000 Trials,10 Million Participants
Surpasses 35,000 trials and 10 million study volunteers worldwide.

[H4]
November 2024

[H3]
Integrates UK Health Costing Data
First to integrate UK-mandated Health Costing Data into its financial management portfolio.

[H4]
February 2025

[H3]
Another Milestone
Surpasses 36,000 Clinical Trials and 11 Million Participants

[H4]
March 2025

[H3]
Launches Site Insights Program
Elevating the Site Voice and strengthening site partnership and performance in clinical trials.

[H4]
MARCH 2025

[H3]
Launches Protocol Optimization
Unveils Protocol Optimization at ASCO, advancing data-driven study design and execution.

[H4]
May2025

[H2]
Trust and Transparency
Your innovations must be as trustworthy as they are transformative. That’s why every AI capability is built on secure data practices, explainable models, and accountable governance. 

Ethical, human-centered intelligence helps you move faster—
while protecting patients, data, and regulatory integrity.

Learn More

[H2]
Values and Corporate Social Responsibility
Our industry-leading CSR program helps you partner with a company built for long-term, responsible growth. Aligned with our parent company’s goal of carbon neutrality by 2040, we invest in sustainable innovation, build strategic partnerships, and continuously strengthen employee expertise—so your trials advance with resilience, accountability, and measurable impact.

[H3]
IMPACT

[H4]
Social Innovation Lab

SIL is a skills-based volunteering program that pairs employees with non-profit partners—working on priority projects that NPOs don’t have the resources to drive.

[H4]
Supporting STEM Innovation

Medidata can provide funds for STEM education, mentor students, and offer insight into the exciting world of life sciences. Our partners include Girls Who Code, All Star Code, and Career Spring.

[H4]
Gift Matching

Causes that matter to our employees matter to us. We matched approximately $350,000 of employee donations to causes they are passionate about in their communities.

[H4]
Sustainability

We measure our progress toward carbon neutrality by 2040 by reporting under Dassault Systèmes as a subsidiary for global environmental, social, and governance (ESG) management.

[H2]
Awards and Recognition

[H6]
2024
IDC MarketScape Worldwide Life Science R&D DCT Technology Solutions and Consulting Services

[H6]
2025
Medidata x Cogstate PartnershipBest Clinical Trial Technology Solution Provider

[H6]
2023 & 2024
Everest Group Life Sciences Clinical Data and Analytics (D&A) Platforms

[H6]
2022 & 2023
Everest Group Decentralized Clinical Trial Platforms

View All Awards

[H3]
Our CSR Programs Have Supported

students in STEM
0
K+

patients with access to care
0
K

volunteer hours
0
K

[H3]
PROJECT PARTNERS

[H1] Resource Library

Gain exclusive clinical trial insights and learn how Medidata’s offerings are solving the latest industry challenges.

[H2]
Protected: 2026 ASCO: Efficacy of Tocilizumab in Resolving CAR T–Induced CRS
Read More

[H2]
Protected: 2026 ASCO: Quantifying the impact of protocol design on enrollment and dropout rates in breast cancer clinical trials
Read More

[H2]
Patient Centricity and Trial Design: What Drives Better Outcomes

Patient Experience
Read More

[H2]
The GLP-1 revolution: Measuring what matters beyond weight loss

Patient Experience
Read More

[H2]
Transform Clinical Data Complexity Into Clinical Clarity

Clinical Data Management
Read More

[H2]
On Demand Webinar: Next-Gen eCOA Now: Faster, Smarter, Scalable

Data & AI
Read More

[H2]
eCOA Readiness Assessment

eCOA
Read More

[H2]
Patient Dropout Calculator

Patient Experience
Read More

[H2]
CNS Trials With Sensors To Capture Patient Data Webinar

Sensors
Read More

[H2]
Patient Payments Panel Discussion

Patient Payments
Read More

[H2]
Responsible AI Adoption in Clinical Trials: Best Practices for Clinical Data Managers

Clinical Data Management
Read More

[H2]
Medidata Plus Fact Sheet

Data & AI
Read More

Load More

[H2]
Professional ServicesAccelerating Value Realization
Trials lose momentum when deployments stall, users struggle, and issues surface too late.Medidata Professional Services ensures your solutions are implemented efficiently, adopted effectively, and supported proactively. 
Reduce risk, accelerate performance, and protect compliance 
alongside experts—from planning through optimization.

Download Fact Sheet

[H2]
Realize Value Faster
You need a partner who understands both the science and the systems behind your trials. Leverage deep clinical expertise, platform knowledge, and proven methodologies to help you execute consistently across studies.

[H6]
Adopt New Innovations with Ease

[H6]
Deploy Best Practices Efficiently

[H6]
Expedite User Adoption

[H6]
Proactively Resolve Issues

[H2]
Services across the Trial Lifecycle

Study Build

Consulting

Customer Success

Lifecycle Support

[H3]
Study Build

[H3]
Study Build and Start-up Acceleration
Tight timelines demand precision. Medidata’s Study Build team designs and configures studies efficiently, led by experts who know your standards.Reusable content and standardized integrations reduce build time and rework, accelerating database lock while you retain full data ownership and control.

See Study Build Overview

[H3]
Consulting

[H3]
Strategy and Transformation Consulting
Digital transformation and decentralized trials require coordinated change. Medidata partners with you to align leadership, workflows, and systems to measurable outcomes.With disciplined change management and clear metrics, we help you execute transformation with confidence.

See Consulting Overview

[H3]
Customer Success

[H3]
Customer Success and Account Governance
Outcomes—not activity—define success. Medidata helps you position dedicated customer success leadership, governance, and data-driven insight to meet your strategic goals.We proactively manage performance, drive optimization, and strengthen adoption.

See Customer Success Overview

[H3]
Lifecycle Support

[H3]
Lifecycle Support and Training
Successful trials require prepared teams and coordinated workflows—not just technology.After launch, we provide hands-on support and ongoing education to drive adoption and maintain compliance.

Explore Training

We knew that we could rely on and trust the partnership that Medidata and Moderna has built over the years. And that Medidata would put their most innovative and thoughtful solution to support whatever the need was.

[H6]
Laurie Callen

We have access to our project manager that we’re touching base with every month so that we can talk… and that’s really made a difference.

[H6]
Melita Romasco

As a small company, we’ve had to rely pretty heavily on Medidata as far as their support system and they really helped guide us. We essentially took them on as being our primary go-to for the builds.

[H6]
Erin O’Boyle

[H2]
Featured Resource
[H3]
Onconova Uses Rave EDC, Supported by Medidata Professional Services, to Improve Patient Screening
Medidata Professional Services helped Onconova modernize patient screening with an electronic, standardized workflow—reducing errors, improving oversight, and streamlining study operations.

Read Case Study

[H2]
More Resources
Explore deeper guidance and related materials.

View All Resources

[H2]
Explore Experiences

Discover the Medidata Platform

[H3]
Professional Services

[H3]
PatientExperience

[H3]
DataExperience

[H3]
StudyExperience